Clinical Trial Update: Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP) [Phase 3]

View source ↗

Summary

Open-label Phase 3 safety and tolerability study of COV155 in adults with osteoarthritis (knee or hip) and chronic low back pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain
• Osteoarthritis

Drugs mentioned

• COV155

Snippet

Sponsor: Mallinckrodt | Conditions: Osteoarthritis, Knee, Osteoarthritis, Hip | Phase 3 | Status: COMPLETED